Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs GANGA PHARMACEUTICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES GANGA PHARMACEUTICALS DIVIS LABORATORIES/
GANGA PHARMACEUTICALS
 
P/E (TTM) x 66.0 - - View Chart
P/BV x 7.1 2.2 329.9% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 DIVIS LABORATORIES   GANGA PHARMACEUTICALS
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
GANGA PHARMACEUTICALS
Mar-23
DIVIS LABORATORIES/
GANGA PHARMACEUTICALS
5-Yr Chart
Click to enlarge
High Rs4,64115 30,333.0%   
Low Rs2,7308 35,000.0%   
Sales per share (Unadj.) Rs292.66.4 4,593.7%  
Earnings per share (Unadj.) Rs68.70.1 71,502.8%  
Cash flow per share (Unadj.) Rs81.60.2 34,515.2%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs480.913.4 3,582.7%  
Shares outstanding (eoy) m265.474.06 6,538.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.61.8 694.4%   
Avg P/E ratio x53.7119.5 44.9%  
P/CF ratio (eoy) x45.249.1 91.9%  
Price / Book Value ratio x7.70.9 890.3%  
Dividend payout %43.70-   
Avg Mkt Cap Rs m978,37847 2,085,648.9%   
No. of employees `000NANA-   
Total wages/salary Rs m9,7500 2,378,097.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,67526 300,367.7%  
Other income Rs m3,4473 115,657.7%   
Total revenues Rs m81,12229 281,184.4%   
Gross profit Rs m23,6910 47,382,200.0%  
Depreciation Rs m3,4321 612,821.4%   
Interest Rs m202 1,010.3%   
Profit before tax Rs m23,6861 4,469,113.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,4530 3,894,642.9%   
Profit after tax Rs m18,2340 4,675,333.3%  
Gross profit margin %30.50.2 16,675.2%  
Effective tax rate %23.026.1 88.3%   
Net profit margin %23.51.5 1,544.3%  
BALANCE SHEET DATA
Current assets Rs m97,43751 189,309.1%   
Current liabilities Rs m15,33119 80,901.3%   
Net working cap to sales %105.7125.8 84.0%  
Current ratio x6.42.7 234.0%  
Inventory Days Days8310 2.7%  
Debtors Days Days842125,511 0.7%  
Net fixed assets Rs m51,12828 180,218.2%   
Share capital Rs m53141 1,307.0%   
"Free" reserves Rs m127,14014 915,334.8%   
Net worth Rs m127,67155 234,258.5%   
Long term debt Rs m06 0.0%   
Total assets Rs m148,56580 186,078.8%  
Interest coverage x1,209.51.3 94,996.0%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.50.3 161.4%   
Return on assets %12.32.9 421.2%  
Return on equity %14.30.7 1,980.1%  
Return on capital %18.64.1 458.0%  
Exports to sales %85.70-   
Imports to sales %19.80-   
Exports (fob) Rs m66,537NA-   
Imports (cif) Rs m15,378NA-   
Fx inflow Rs m66,5370-   
Fx outflow Rs m15,7150-   
Net fx Rs m50,8220-   
CASH FLOW
From Operations Rs m24,5970 -6,149,325.0%  
From Investments Rs m-27,0765 -550,329.3%  
From Financial Activity Rs m-7,972-4 179,542.8%  
Net Cashflow Rs m-10,4510 -11,611,777.8%  

Share Holding

Indian Promoters % 51.9 56.0 92.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.7 0.0 -  
FIIs % 14.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 44.0 109.3%  
Shareholders   354,482 362 97,923.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs GANGA PHARMACEUTICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs GANGA PHARMACEUTICALS Share Price Performance

Period Divis Laboratories GANGA PHARMACEUTICALS S&P BSE HEALTHCARE
1-Day 2.14% -4.98% 1.18%
1-Month -2.15% -5.20% -0.75%
1-Year 22.51% 87.77% 61.82%
3-Year CAGR -1.38% 59.64% 18.16%
5-Year CAGR 15.77% 32.40% 19.79%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the GANGA PHARMACEUTICALS share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of GANGA PHARMACEUTICALS the stake stands at 56.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of GANGA PHARMACEUTICALS.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

GANGA PHARMACEUTICALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of GANGA PHARMACEUTICALS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.